drugset / Trial / NCT02038972
Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss
NaSingle-groupOpen-labelTreatment
Summary
To determine if autologous human umbilical cord blood infusion in children with acquired hearing loss is safe, feasible, improves inner ear function, audition and language development.
Timeline
- Start
- 2013-01
- Primary completion
- 2015-12-11
- Completion
- 2017-01-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous Stem Cells | Cell therapy | 6e+06 cells/kg | Intravenous |